Drugs that contain Tadalafil

1. List of Tadliq drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US11382917 CMP DEV LLC Liquid oral formulations for tadalafil
Dec, 2038

(15 years from now)

Do you want to check out TADLIQ patents from before 2022?

Market Authorisation Date: 17 June, 2022

Treatment: Tadliq is indicated for the treatment of pulmonary arterial hypertension (pah) (who group 1) to improve exercise ability

Dosage: SUSPENSION;ORAL

More Information on Dosage

TADLIQ family patents

6

United States

2

India

IB

1

IB

1

China

1

Brazil

1

Canada

1

Morocco

1

Singapore

1

Japan

1

Australia

1

European Union

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in